Oral Dis 2009,15(6):388–399.PubMedCrossRef

4. Altekruse SF KC, Krapcho M, Neyman N, Aminou R, Waldron W, Ruhl J, Howlader N, Tatalovich Z, Cho H (Eds): SEER Cancer Statistics Review, 1975–2008. Bethesda, MD: National Cancer Institute; 1975–2008. posted to the SEER web site, 2011, based on November 2010 SEER data submission 5. Johnson NW, Jayasekara P, Amarasinghe AAHK: Squamous cell carcinoma and Momelotinib precursor lesions of the oral cavity: epidemiology and aetiology. Periodontol 2011,57(1):19–37.CrossRef 6. Tanaka T, Tanaka M, Tanaka T: Oral carcinogenesis and oral cancer chemoprevention: learn more a review. Pathol Res Int 2011 2011, 10 pages. Article ID 431246 7. Tsantoulis PK, Kastrinakis NG, Tourvas AD, Laskaris G, Gorgoulis VG: Advances in the biology of oral cancer. Oral Oncol 2007,43(6):523–534.PubMedCrossRef 8. Lax AJ, Thomas W: How bacteria could cause cancer: one step at a time. Trends Microbiol 2002,10(6):293–299.PubMedCrossRef

9. Pujol FH, Devesa M: Genotypic variability of hepatitis viruses associated with chronic infection and the development of hepatocellular carcinoma. J Clin Gastroenterol 2005,39(7):611–618.PubMedCrossRef 10. Nagy KN, Sonkodi I, Szoke I, Nagy E, Newman HN: The microflora associated with human oral carcinomas. Oral Oncol 1998,34(4):304–308.PubMed Fedratinib 11. Sharma Mohit Bairy I, Pai K, Satyamoorthy K, Prasad S, Berkovitz B, Radhakrishnan R: Salivary IL-6 levels in oral leukoplakia with dysplasia and its clinical relevance to tobacco habits and periodontitis. Clin Oral Invest 2010,15(5):705–714.CrossRef 12. Tezal M, Sullivan MA, Hyland A, Marshall JR,

Stoler D, Reid ME, Loree TR, Rigual NR, Merzianu M, Hauck L, et al.: Chronic periodontitis and the incidence of head and neck squamous cell carcinoma. Cancer Epidemiol Biomarkers Prev 2009,18(9):2406–2412.PubMedCrossRef Monoiodotyrosine 13. Lissowska J, Pilarska A, Pilarski P, Samolczyk-Wanyura D, Piekarczyk J, Bardin-Mikollajczak A, Zatonski W, Herrero R, Munoz N, et al.: Smoking, alcohol, diet, dentition and sexual practices in the epidemiology of oral cancer in Poland. Eur J Cancer Prev 2003,12(1):25–33.PubMedCrossRef 14. Hooper SJ, Wilson MJ, Crean SJ: Exploring the link between microorganisms and oral cancer: a systematic review of the literature. Head Neck 2009,31(9):1228–1239.PubMedCrossRef 15. Lax AJ: Opinion: bacterial toxins and cancer-a case to answer? Nat Rev Microbiol 2005,3(4):343–349.PubMedCrossRef 16. Mantovani A, Garlanda C, Allavena P: Molecular pathways and targets in cancer-related inflammation. Ann Med 2010,42(3):161–170.PubMedCrossRef 17. Meurman J: Oral microbiota and cancer. J Oral Microbiol 2010, 2:5195. 18. Tsai HF, Hsu PN: Interplay between Helicobacter pylori and immune cells in immune pathogenesis of gastric inflammation and mucosal pathology. Cell Mol Immunol 2010,7(4):255–259.PubMedCrossRef 19. Mager DL: Bacteria and cancer: cause, coincidence or cure? a revie.